Study identifies immune proteins shielding cancer cells from T-cell attack

The proteins counteract the inflammatory effects of interferon-γ, a cytokine released during immune activity. The study focuses on mechanisms that protect tumor cells from programmed cell death. Researchers examined how these proteins interfere with interferon-γ signaling pathways that normally promote cell death.

Research findings The findings detail a specific interaction between the signaling proteins and interferon-γ pathways. This interaction reduces the effectiveness of T-cell-mediated killing of cancer cells. The work provides a mechanistic explanation for observed resistance in some tumors. It identifies molecular steps that occur after interferon-γ exposure.

Next steps Further experiments are needed to determine whether blocking these proteins increases tumor cell death in laboratory models. The study does not report results from animal or human trials.